Evidence map›Paper›PMID 42509340›Full record

ArticleDie Ophthalmologie2026

[Prepapillary vitreous exudate as the first ocular manifestation of Behçet's disease: A case report].

Syrine Feki, Adrian Skowronski, Esra Kardes, Markus Kohlhaas

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Syrine FekiKlinik für Augenheilkunde, St.-Johannes-Hospitals, Dortmund, Deutschland. feki.syrine@yahoo.fr.ORCID http://orcid.org/0009-0004-0122-6527
Adrian SkowronskiKlinik für Augenheilkunde, St.-Johannes-Hospitals, Dortmund, Deutschland.
Esra KardesKlinik für Augenheilkunde, St.-Johannes-Hospitals, Dortmund, Deutschland.
Markus KohlhaasKlinik für Augenheilkunde, St.-Johannes-Hospitals, Dortmund, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBehçet's disease is a systemic inflammatory disorder that frequently presents with ocular involvement in the form of non-granulomatous panuveitis and retinal vasculitis. A prepapillary inflammatory vitreous infiltrate represents a rare but potentially characteristic manifestation. CASE REPORT: We report the case of a 29-year-old female patient presenting with acute, painless visual loss in the right eye. Clinical examination revealed non-granulomatous anterior uveitis with bilateral vitritis and a prepapillary inflammatory vitreous infiltrate in the right eye. Optical coherence tomography (OCT) demonstrated a typical mushroom-shaped prepapillary infiltrate associated with serous macular detachment. Fluorescein angiography revealed optic disc and peripheral leakage. Infectious causes were excluded. In the context of recurrent oral and genital aphthous ulcers, the patient fulfilled the diagnostic criteria for Behçet's disease. TREATMENT AND OUTCOME: Following intravenous high-dose corticosteroid pulse therapy, treatment with adalimumab was initiated. This resulted in significant functional and anatomical improvement, with regression of the prepapillary inflammatory vitreous infiltrate and the serous retinal detachment.

conclusionA prepapillary inflammatory vitreous infiltrate is a rare but important diagnostic sign of ocular Behçet's disease and may be a key finding, particularly in patients presenting with initial ocular involvement. Early diagnosis and prompt initiation of immunosuppressive therapy are essential for visual prognosis.

Indexed as

AdalimumabOptical coherence tomographyPanuveitisRetinal vasculitisUveitis

Identifiers

PMID42509340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.